guilherme henrique espíndola efeitos adversos dos ... - UFSC

12. Martinez E, Tuset M, Milinkovic A, Miro JM, Gatell JM. Management ofdyslipidaemia in HIV-infected patients receiving antiretroviral therapy. InfectiousDiseases, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.13. Melvin AJ, Lennon S, Mohan KM, Purnell JQ. Metabolic abnormalities in HIV type1-infected children treated and not treated with protease inhibitors. AIDS Res HumRetroviruses 2001;17: 1117-23.14. Carr A, Cooper DA. Adverse effects of ARVT. Lancet 2000;356: 1423-3015. Lee Ecc, Walmsley S. Fantus IG. New-onset diabetes mellitus associated withprotease inhibitor therapy in HIV positive patient. Case of report and rewiew. CMAJ1999;161(2): 161-416. Walli R, Herfort O, Michl GM, Demant T, Jager H, Dieterle C, et al. Treatment withprotease inhibitors associated with peripheral insulin resistance and impaired oralglucose tolerance in HIV -1- infected patients. AIDS 1998;12: F167-73.17. Dube MP. Disorders of glucose metabolism in patients infected with humanimmunodeficiency vírus. Clin. Infec.Disease 2000;31: 1467-75.18. Grace A, McComsey and Ethan Leonard, Metabolic complications of HIV therapyin children. AIDS 2004;18: 1753-68.19. Mueller BU, Nelson RPJr, Sleasman J, Zuckeman J, HeathChiozzi M, Steinberg SM,et al. A phase I/II study of the protease inhibitor ritonavir in children with humanimmunodeficiency vírus infection. Pediatrics 1998;101: 335 –43.20. Prevalence of adverse events associated with potent antiretroviral treatment: SWISSHIV Cohort Study. The Lancet 2001 Oct 20;358: 1322-27.21. Unexpected drug interactions and adverse events with antiretroviral drugs. TheLancet 2004 Jul 3;364: 8-10.22. Murphy R. Defining the Toxicity Profile of Nevirapine and Other AntiretroviralDrugs. JAIDS 2003;34: S15-9.23. Protease inhibitors may increase blood glucose in HIV patients. Washington, DC:Food and Drug Administration, 1997.24. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN.Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27-31.